Cargando…
Synthesis of compounds related to the anti-migraine drug eletriptan hydrobromide
Eletriptan hydrobromide (1) is a selective serotonin (5-HT(1)) agonist, used for the acute treatment of the headache phase of migraine attacks. During the manufacture of eletriptan hydrobromide the formation of various impurities were observed and identified by LC–MS. To control the formation of the...
Autores principales: | Madasu, Suri Babu, Vekariya, Nagaji Ambabhai, Kiran, M N V D Hari, Gupta, Badarinadh, Islam, Aminul, Douglas, Paul S, Babu, Korupolu Raghu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Beilstein-Institut
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458767/ https://www.ncbi.nlm.nih.gov/pubmed/23019477 http://dx.doi.org/10.3762/bjoc.8.162 |
Ejemplares similares
-
Pharmacokinetics and tolerability of eletriptan hydrobromide in healthy Korean subjects
por: Kim, Yu Kyong, et al.
Publicado: (2018) -
Statistically Optimized Polymeric Buccal Films of Eletriptan Hydrobromide and Itopride Hydrochloride: An In Vivo Pharmacokinetic Study
por: Safhi, Awaji Y., et al.
Publicado: (2023) -
The Development of Eletriptan Hydrobromide Immediate Release Buccal Films Using Central Composite Rotatable Design: An In Vivo and In Vitro Approach
por: Siddique, Waqar, et al.
Publicado: (2022) -
A review of the pharmacoeconomics of eletriptan for the acute treatment of migraine
por: Bhambri, Rahul, et al.
Publicado: (2015) -
Patient satisfaction with eletriptan in the acute treatment of migraine in primary care
por: Nett, R B, et al.
Publicado: (2007)